Not Tagged
Not Tagged
[]
nanvuralat, lat1 inhibitor, shows promising activity for patients with refractory #cholangioca look forward to seeing more data! #gi23
Medical Director, GI Oncology Program - AdventHealth Cancer Institute. Passionate about clinical research, education and pt-prov communication. #gicancer #meded